65 related articles for article (PubMed ID: 17502674)
1. The use of monoclonal antibodies and lectins to identify changes in viral glycoproteins that are influenced by glycosylation: the case of human respiratory syncytial virus attachment (G) glycoprotein.
Rawling J; Melero JA
Methods Mol Biol; 2007; 379():109-25. PubMed ID: 17502674
[TBL] [Abstract][Full Text] [Related]
2. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein.
García-Beato R; Martínez I; Francí C; Real FX; García-Barreno B; Melero JA
Virology; 1996 Jul; 221(2):301-9. PubMed ID: 8661440
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
Palomo C; Cane PA; Melero JA
J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
[TBL] [Abstract][Full Text] [Related]
4. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.
Palomo C; García-Barreno B; Peñas C; Melero JA
J Gen Virol; 1991 Mar; 72 ( Pt 3)():669-75. PubMed ID: 2005433
[TBL] [Abstract][Full Text] [Related]
5. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
[TBL] [Abstract][Full Text] [Related]
6. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.
Sullender WM; Edwards KG
Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149
[TBL] [Abstract][Full Text] [Related]
7. Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A.
Collins PL; Mottet G
J Gen Virol; 1992 Apr; 73 ( Pt 4)():849-63. PubMed ID: 1634876
[TBL] [Abstract][Full Text] [Related]
8. Effect of breast feeding on the development of anti-idiotype antibody response to F glycoprotein of respiratory syncytial virus in infant mice after post-partum maternal immunization.
Okamoto Y; Tsutsumi H; Kumar NS; Ogra PL
J Immunol; 1989 Apr; 142(7):2507-12. PubMed ID: 2926142
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
Teng MN; Whitehead SS; Collins PL
Virology; 2001 Oct; 289(2):283-96. PubMed ID: 11689051
[TBL] [Abstract][Full Text] [Related]
10. Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years.
Matheson JW; Rich FJ; Cohet C; Grimwood K; Huang QS; Penny D; Hendy MD; Kirman JR
J Med Virol; 2006 Oct; 78(10):1354-64. PubMed ID: 16927286
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus.
Walsh EE; Schlesinger JJ; Brandriss MW
J Gen Virol; 1984 Apr; 65 ( Pt 4)():761-7. PubMed ID: 6707612
[TBL] [Abstract][Full Text] [Related]
12. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization.
Wu H; Pfarr DS; Tang Y; An LL; Patel NK; Watkins JD; Huse WD; Kiener PA; Young JF
J Mol Biol; 2005 Jul; 350(1):126-44. PubMed ID: 15907931
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
McGill A; Marsh R; Craft AW; Toms GL
J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
[TBL] [Abstract][Full Text] [Related]
14. A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9.
Johnson S; Griego SD; Pfarr DS; Doyle ML; Woods R; Carlin D; Prince GA; Koenig S; Young JF; Dillon SB
J Infect Dis; 1999 Jul; 180(1):35-40. PubMed ID: 10353858
[TBL] [Abstract][Full Text] [Related]
15. Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus.
Sullender W
Virology; 1995 May; 209(1):70-9. PubMed ID: 7747486
[TBL] [Abstract][Full Text] [Related]
16. Mapping of monoclonal antibody epitopes of the human respiratory syncytial virus p protein.
García J; García-Barreno B; Martinez I; Melero JA
Virology; 1993 Jul; 195(1):239-42. PubMed ID: 7686311
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner.
García-Beato R; Melero JA
J Gen Virol; 2000 Apr; 81(Pt 4):919-27. PubMed ID: 10725417
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus glycoprotein expression in human and simian cell lines.
Routledge EG; Willcocks MM; Samson AC; Scott R; Toms GL
J Gen Virol; 1986 Sep; 67 ( Pt 9)():2059-64. PubMed ID: 2427648
[TBL] [Abstract][Full Text] [Related]
19. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Johnson TR; Graham BS
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus.
Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P
J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
